10/31/14 COO 163.90 Cooper Companies $COO Hit a 52
Post# of 52
Posted On: 11/01/2014 11:38:59 PM
10/31/14 COO 163.90 Cooper Companies $COO Hit a 52 week high of 166.52 Closing the day 10/31/14 at 163.90 +0.24 +0.15% With a day low of 163.19 and a total volume of 371,000.
COO Recent Posts: http://investorshangout.com/Cooper-Companies-COO-50592/
COO Cooper Companies Recent Headline News
Cardinal Health (CAH) Beats on Q1 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:41AM CDT
Cardinal Health (CAH) reported first-quarter fiscal 2015 earnings of $1.00 per share, which beat the Zacks Consensus Estimate by 3 cents.
CAH: 78.48 (+0.29), CVS: 85.81 (+0.26), COO: 163.90 (+0.24), WAG: 64.22 (+1.26)
Tornier N.V. (TRNX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:46AM CDT
Tornier N.V. (TRNX) was a big mover last session, with shares rising nearly 8% on the day.
CAH: 78.48 (+0.29), TRNX: 27.95 (-0.11), HSIC: 120.03 (-0.18), COO: 163.90 (+0.24)
Invacare Corporation (IVC) in Focus: Stock Surges 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:18AM CDT
Invacare Corporation (IVC) was a big mover last session, as the company saw its shares nearly 15% on the day.
IVC: 15.71 (+0.01), CAH: 78.48 (+0.29), COO: 163.90 (+0.24)
CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 61.80 (+0.96), CNMD: 41.99 (-0.05), COO: 163.90 (+0.24)
CR Bard Beats Q3 Earnings and Revenues, '14 View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 7:50AM CDT
For 2014, CR Bard Inc. (BCR) increased its adjusted earnings per share guidance to the band of $ 8.34-$8.38 from the prior range of $8.25-$8.35.
BCR: 163.97 (+2.98), CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), COO: 163.90 (+0.24)
Patterson Companies, Quality Systems Ink Dental Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 4:38PM CDT
Through this partnership, Quality Systems Inc. (QSII) intends to leverage Patterson Companies, Inc.'s (PDCO) special market division sales force to set up a new line of business with its dental group practice customers.
ABAX: 52.66 (+1.13), PDCO: 43.11 (+0.47), QSII: 15.11 (+0.17), COO: 163.90 (+0.24)
DENTSPLY International Grows on Product Innovation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 12:10PM CDT
DENTSPLY International's (XRAY) overall growth strategy rests on product innovation.
CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Steris (STE) to Buy UK-based Synergy Health, Save Tax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 2:30PM CDT
Following this news, Steris' (STE) share price inched up 0.3% immediately, but eventually dropped 2.5% to close at $54.99 yesterday.
STE: 61.80 (+0.96), CAH: 78.48 (+0.29), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Becton, Dickinson Acquires GenCell Biosystems in Ireland - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 12:10PM CDT
The GenCell acquisition will enable Becton, Dickinson and Company (BDX) to offer a differentiated platform in the NGS market, constructing a base to further expand its genomics offerings.
BDX: 128.70 (+1.18), CAH: 78.48 (+0.29), CFN: 57.37 (-0.15), COO: 163.90 (+0.24)
CR Bard's Lutonix 035: First FDA-Approved DCB in the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:20PM CDT
The FDA approval for CR Bard's (BCR) Lutonix 035 DCB comes on the heels of a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel in Jun 2014.
BCR: 163.97 (+2.98), CAH: 78.48 (+0.29), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Henry Schein's BioHorizons Unveils MinerOss X Xenografts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:00PM CDT
We believe the launch of the MInerOss X family of xenografts products by BioHorizons will buoy Henry Schein's (HSIC) profitability further in the global implant market.
CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Cooper (COO) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 7:22AM CDT
Cooper (COO) Enters Oversold Territory
COO: 163.90 (+0.24)
Cardinal Health and Ohio State Open Pharma Center - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:44PM CDT
The molecular imaging pharmaceuticals center will combine Ohio State's Wright Center of Innovation in Biomedical Imaging's research capabilities with Cardinal Health's (CAH) developmental, manufacturing and commercialization expertise
CAH: 78.48 (+0.29), LH: 109.29 (+1.90), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
The Cooper Companies Acquires EndoSee for $44 Million - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 12:40PM CDT
The acquisition of EndoSee is expected to be neutral to The Cooper Companies Inc.'s (COO) fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
The Cooper Companies' Women's Healthcare Unit Acquires EndoSee
GlobeNewswire - Wed Oct 08, 3:01PM CDT
The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women's healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system. The transaction is valued at approximately $44 million and is expected to be neutral to fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
COO: 163.90 (+0.24)
Becton, Dickinson (BDX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:46AM CDT
Becton, Dickinson (BDX) was a big mover last session, with shares rising nearly 8% on the day.
BDX: 128.70 (+1.18), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
Becton, Dickinson Signs $12.2B Deal to Acquire CareFusion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 12:40PM CDT
The acquisition is expected to accelerate Becton, Dickinson and Company's (BDX) strategy to improve quality of care, increase efficiencies, reduce healthcare costs and enhance emerging market growth opportunities.
BDX: 128.70 (+1.18), GS: 189.99 (+3.02), CFN: 57.37 (-0.15), COO: 163.90 (+0.24)
Cardinal Health Unit and KEW Group Unite to Treat Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 12:10PM CDT
Cardinal Health Inc.'s (CAH) community oncologists will enjoy access to KEW's advanced diagnostics tools, enabling them to provide personalized medicine treatments.
MCK: 203.41 (-0.07), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
Endologix (ELGX) Crumbles: Stock Plunges by 18.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 7:48AM CDT
Endologix stock fell over 18% last trading session, continuing its recent downtrend
ABC: 85.41 (+0.57), LH: 109.29 (+1.90), ELGX: 11.40 (+0.16), COO: 163.90 (+0.24)
Becton, Dickinson Sees Strong International Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 4:22PM CDT
Becton, Dickinson and Company (BDX) maintains its focus on expansion into overseas markets, in particular, emerging markets, which accounted for about 60% of sales in the third quarter of fiscal 2014.
BDX: 128.70 (+1.18), MCK: 203.41 (-0.07), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
COO Recent Posts: http://investorshangout.com/Cooper-Companies-COO-50592/
COO Cooper Companies Recent Headline News
Cardinal Health (CAH) Beats on Q1 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:41AM CDT
Cardinal Health (CAH) reported first-quarter fiscal 2015 earnings of $1.00 per share, which beat the Zacks Consensus Estimate by 3 cents.
CAH: 78.48 (+0.29), CVS: 85.81 (+0.26), COO: 163.90 (+0.24), WAG: 64.22 (+1.26)
Tornier N.V. (TRNX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:46AM CDT
Tornier N.V. (TRNX) was a big mover last session, with shares rising nearly 8% on the day.
CAH: 78.48 (+0.29), TRNX: 27.95 (-0.11), HSIC: 120.03 (-0.18), COO: 163.90 (+0.24)
Invacare Corporation (IVC) in Focus: Stock Surges 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:18AM CDT
Invacare Corporation (IVC) was a big mover last session, as the company saw its shares nearly 15% on the day.
IVC: 15.71 (+0.01), CAH: 78.48 (+0.29), COO: 163.90 (+0.24)
CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 61.80 (+0.96), CNMD: 41.99 (-0.05), COO: 163.90 (+0.24)
CR Bard Beats Q3 Earnings and Revenues, '14 View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 7:50AM CDT
For 2014, CR Bard Inc. (BCR) increased its adjusted earnings per share guidance to the band of $ 8.34-$8.38 from the prior range of $8.25-$8.35.
BCR: 163.97 (+2.98), CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), COO: 163.90 (+0.24)
Patterson Companies, Quality Systems Ink Dental Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 4:38PM CDT
Through this partnership, Quality Systems Inc. (QSII) intends to leverage Patterson Companies, Inc.'s (PDCO) special market division sales force to set up a new line of business with its dental group practice customers.
ABAX: 52.66 (+1.13), PDCO: 43.11 (+0.47), QSII: 15.11 (+0.17), COO: 163.90 (+0.24)
DENTSPLY International Grows on Product Innovation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 12:10PM CDT
DENTSPLY International's (XRAY) overall growth strategy rests on product innovation.
CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Steris (STE) to Buy UK-based Synergy Health, Save Tax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 2:30PM CDT
Following this news, Steris' (STE) share price inched up 0.3% immediately, but eventually dropped 2.5% to close at $54.99 yesterday.
STE: 61.80 (+0.96), CAH: 78.48 (+0.29), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Becton, Dickinson Acquires GenCell Biosystems in Ireland - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 12:10PM CDT
The GenCell acquisition will enable Becton, Dickinson and Company (BDX) to offer a differentiated platform in the NGS market, constructing a base to further expand its genomics offerings.
BDX: 128.70 (+1.18), CAH: 78.48 (+0.29), CFN: 57.37 (-0.15), COO: 163.90 (+0.24)
CR Bard's Lutonix 035: First FDA-Approved DCB in the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:20PM CDT
The FDA approval for CR Bard's (BCR) Lutonix 035 DCB comes on the heels of a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel in Jun 2014.
BCR: 163.97 (+2.98), CAH: 78.48 (+0.29), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Henry Schein's BioHorizons Unveils MinerOss X Xenografts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:00PM CDT
We believe the launch of the MInerOss X family of xenografts products by BioHorizons will buoy Henry Schein's (HSIC) profitability further in the global implant market.
CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Cooper (COO) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 7:22AM CDT
Cooper (COO) Enters Oversold Territory
COO: 163.90 (+0.24)
Cardinal Health and Ohio State Open Pharma Center - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:44PM CDT
The molecular imaging pharmaceuticals center will combine Ohio State's Wright Center of Innovation in Biomedical Imaging's research capabilities with Cardinal Health's (CAH) developmental, manufacturing and commercialization expertise
CAH: 78.48 (+0.29), LH: 109.29 (+1.90), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
The Cooper Companies Acquires EndoSee for $44 Million - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 12:40PM CDT
The acquisition of EndoSee is expected to be neutral to The Cooper Companies Inc.'s (COO) fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
CAH: 78.48 (+0.29), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
The Cooper Companies' Women's Healthcare Unit Acquires EndoSee
GlobeNewswire - Wed Oct 08, 3:01PM CDT
The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women's healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system. The transaction is valued at approximately $44 million and is expected to be neutral to fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
COO: 163.90 (+0.24)
Becton, Dickinson (BDX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:46AM CDT
Becton, Dickinson (BDX) was a big mover last session, with shares rising nearly 8% on the day.
BDX: 128.70 (+1.18), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
Becton, Dickinson Signs $12.2B Deal to Acquire CareFusion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 12:40PM CDT
The acquisition is expected to accelerate Becton, Dickinson and Company's (BDX) strategy to improve quality of care, increase efficiencies, reduce healthcare costs and enhance emerging market growth opportunities.
BDX: 128.70 (+1.18), GS: 189.99 (+3.02), CFN: 57.37 (-0.15), COO: 163.90 (+0.24)
Cardinal Health Unit and KEW Group Unite to Treat Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 12:10PM CDT
Cardinal Health Inc.'s (CAH) community oncologists will enjoy access to KEW's advanced diagnostics tools, enabling them to provide personalized medicine treatments.
MCK: 203.41 (-0.07), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
Endologix (ELGX) Crumbles: Stock Plunges by 18.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 7:48AM CDT
Endologix stock fell over 18% last trading session, continuing its recent downtrend
ABC: 85.41 (+0.57), LH: 109.29 (+1.90), ELGX: 11.40 (+0.16), COO: 163.90 (+0.24)
Becton, Dickinson Sees Strong International Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 4:22PM CDT
Becton, Dickinson and Company (BDX) maintains its focus on expansion into overseas markets, in particular, emerging markets, which accounted for about 60% of sales in the third quarter of fiscal 2014.
BDX: 128.70 (+1.18), MCK: 203.41 (-0.07), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
(0)
(0)Cooper Companies (COO) Stock Research Links
Scroll down for more posts ▼